About Us
Medidect India
Millennium Oncology India Private Limited (operating under trade name Medidect India) has partnered with Zyagnum AG, acquiring exclusive rights to deploy a breakthrough technology for tumors screening across India. We are legally registered under the name of MILLENNIUM ONCOLOGY INDIA PRIVATE LIMITED
PanTum Detect is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 82% is validated and unique to this day. With the successful EU-IVDR and Indian registration, Pantum Detect is the first, and so far, the only universal (all solid cancer types) screening blood test for structured, fast and inexpensive multi-cancer screening.
Medidect India will build and leverage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.
PanTum Detect is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 82% is validated and unique to this day. With the successful EU-IVDR and Indian registration, Pantum Detect is the first, and so far, the only universal (all solid cancer types) screening blood test for structured, fast and inexpensive multi-cancer screening.
Medidect India will build and leverage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.
About Us
Medidect™ India
Millennium Oncology India Private Limited (operating under trade name Medidect™ India) has partnered with Zyagnum AG, acquiring exclusive rights to deploy a breakthrough technology for tumors screening across India. We are legally registered under the name of MILLENNIUM ONCOLOGY INDIA PRIVATE LIMITED
PanTum® Detect is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 97.5% is validated and unique to this day. With the successful IVD CE and Indian registration, Pantum® Detect is the first, and so far, the only universal (all solid cancer types) screening blood test for structured, fast and inexpensive multi-cancer screening.
Medidect™ India will build and leverage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.
PanTum® Detect is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 97.5% is validated and unique to this day. With the successful IVD CE and Indian registration, Pantum® Detect is the first, and so far, the only universal (all solid cancer types) screening blood test for structured, fast and inexpensive multi-cancer screening.
Medidect™ India will build and leverage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.
OUR EXPERTSFounding Members
CO-FOUNDER & DIRECTOR
Dr. Gurdeep Singh Sethi, MD
Founder & Director, Millennium Cancer Center, India. Has over 30 years of experience in cancer management and immuno-oncology. He has spent over 26 years in the USA as a Senior Partner at an oncology chain. Practicing in India since 2015.
CO-FOUNDER & DIRECTOR
Gagandeep Singh Bedi
Healthcare leader bringing over 30 years of experience from roles at Philips Healthcare & Fortis Healthcare. With expertise in healthcare spanning Europe, Middle East, Africa, South America, South-east Asia and India, he holds deep understanding of healthcare delivery and financing.
CO-FOUNDER & DIRECTOR
Andreas Klein
Over 25 years in leadership roles in Europe, US, China and Asia and experience in international business management . He is also an advisor to the board of Zyagnum.
Leadership Team
Consultant & Market Access Partner
ARPAN DIXIT
An accomplished leadership professional with experience in introducing innovative technology platforms with high socio-economic impact across India, Mr. Dixit supports MOIPL’s mission of providing equitable access to the full-body cancer health-check blood test through the mass participation of healthy residents of India in the Cancer Mukt Bharat Project.
Lab Director
Dr. Pramod Nath
Renowned Oncopathologist with 32 yrs of total experience in healthcare industry including 23 yrs in Armed Forces. Expertise in Histopathology & Cytology. Has been lab director & HOD in reputed hospitals.
Professional Advisors
Advisor
Rajiv Kapahi
Over 3 decades of experience in multi-industry domain as CXO & Board level engagements across MNC’s & Indian Business Houses in Healthcare, Insurance, IT / ITES, FMCG, Manufacturing & Office Automation sectors in India, APAC & EMEA.
Licences & Certifications
Connect with us for any queries
Connect with us for any queries